
Am J Psychiatry 156:1608-1617, October 1999
© 1999 American Psychiatric Association
Treatment of Primary Dysthymia With Group Cognitive Therapy and Pharmacotherapy: Clinical Symptoms and Functional Impairments
Arun V. Ravindran, M.D., Ph.D.,
Hymie Anisman, Ph.D.,
Zul Merali, Ph.D.,
Yoland Charbonneau, M.D.,
John Telner, Ph.D.,
Robert J. Bialik, Ph.D.,
Andrew Wiens, M.D.,
Jack Ellis, M.D., and
Jenna Griffiths, Ph.D.
OBJECTIVE: This study assessed the efficacy of antidepressant treatment (sertraline) and group cognitive behavior therapy, alone or in combination, in primary dysthymia. The clinical features of dysthymia, as well as the functional impairments associated with the illness (e.g., quality of life, stress perception, coping styles), were evaluated. METHOD: Patients (N=97) diagnosed with primary dysthymia, but no other current comorbid disorder, received either sertraline or placebo in a double-blind design over 12 weeks. In addition, a subgroup of the patients (N=49) received a structured, weekly group cognitive behavior therapy intervention. RESULTS: Treatment with sertraline, with or without group cognitive behavior therapy, reduced the functional impairment of depression. The reductions were similar in the drug-cognitive therapy group and in subjects who received the drug alone. Furthermore, while group cognitive behavior therapy alone reduced the depression scores, this effect was not significantly greater than the effect of the placebo. The drug treatment also induced pronounced improvement in the functional measures, and in some respects these effects were augmented by group cognitive behavior therapy. Among patients who responded favorably to cognitive behavior therapy, the improvements in the functional measures were similar to those who responded to drug treatment, whereas such functional changes were not seen among patients who responded to placebo. CONCLUSIONS: Sertraline treatment effectively reduces the clinical symptoms and functional impairments associated with dysthymia. Although the group cognitive behavior therapy intervention was less effective in alleviating clinical symptoms, it augmented the effects of sertraline with respect to some functional changes, and in a subgroup of patients it attenuated the functional impairments characteristic of dysthymia.
This article has been cited by other articles:

|
 |

|
 |
 
E. Frank, D. J. Kupfer, M. E. Thase, A. G. Mallinger, H. A. Swartz, A. M. Fagiolini, V. Grochocinski, P. Houck, J. Scott, W. Thompson, et al.
Two-Year Outcomes for Interpersonal and Social Rhythm Therapy in Individuals With Bipolar I Disorder
Arch Gen Psychiatry,
September 1, 2005;
62(9):
996 - 1004.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Jindal and M. E. Thase
Integrating Psychotherapy and Pharmacotherapy to Improve Outcomes Among Patients With Mood Disorders
Focus,
January 1, 2005;
3(1):
114 - 121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pampallona, P. Bollini, G. Tibaldi, B. Kupelnick, and C. Munizza
Combined Pharmacotherapy and Psychological Treatment for Depression: A Systematic Review
Arch Gen Psychiatry,
July 1, 2004;
61(7):
714 - 719.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Jindal and M. E. Thase
Integration of Care: Integrating Psychotherapy and Pharmacotherapy to Improve Outcomes Among Patients With Mood Disorders
Psychiatr Serv,
November 1, 2003;
54(11):
1484 - 1490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Remick
Diagnosis and management of depression in primary care: a clinical update and review
Can. Med. Assoc. J.,
November 26, 2002;
167(11):
1253 - 1260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. O. Gabbard and J. Kay
The Fate of Integrated Treatment: Whatever Happened to the Biopsychosocial Psychiatrist?
Am J Psychiatry,
December 1, 2001;
158(12):
1956 - 1963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Thase
Scientific Foundations of Cognitive Theory and Therapy of Depression
J Psychother Pract Res.,
October 1, 2001;
10(4):
286 - 287.
[Full Text]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 1999
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|